Assistant Secretary for Legislation (ASL)

Testimony

Calendar Year 2005 Congressional Testimony

2007~2006~2005~2004~2003~2002~2001~2000~1999~1998~1997~1996
Jan~Feb~Mar~Apr~May~Jun~Jul~Aug~Sep~Oct~Nov~Dec

December 15, 2005-- Dennis P. Williams, Deputy Administrator, Health Resources and Services Administration, HHS
Subject: Oversight and Administration of the 340B Drug Pricing Program (340B Program)
Before: Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, United States House of Representatives

December 15, 2005-- Denise Cardo, M.D., Director, Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Avian Influenza: Preparing for a Possible Influenza Pandemic
Before: Veterans' Affairs Subcommittee on Oversight and Investigations, United States House of Representatives

December 8, 2005-- National Institutes of Health, U.S. Department of Health and Human Services
Subject: An Update of NIH Pain Research and Related Program Initiatives
Before: Statement for the Record, Subcommittee on Health, Committee on Energy and Commerce, United States House of Representatives

December 8, 2005-- Mark T. Gladwin, M.D., Chief, Vascular Medicine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Improving America's Health: Examining Federal Research Efforts for Pulmonary Hypertension
Before: Subcommittee on Health, Committee on Energy and Commerce, United States House of Representatives

December 7, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Pandemic Influenza: The Road to Preparedness
Before: The Committee on International Relations, United States House of Representatives

December 7, 2005-- Anne Schuchat, M.D., Acting Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Avian Influenza: Preparing for a Possible Influenza Pandemic
Before: The Committee on International Relations, United States House of Representatives

November 17, 2005-- Mark B. McClellan, M.D., PH.D., Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Medicare Physician Payments
Before: The House Committee on Energy and Commerce, Subcommittee on Health

November 17, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Agricultural Role in Controlling and Eradicating Avian Influenza
Before: The United States Committee on Agriculture, Nutrition and Forestry

November 9, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Avain Influenza: Preparing for a possible Influenza Pandemic
Before: The Committee on Foreign Relations, United States Senate

November 9, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Pandemic Influenza: The Road to Preparedness
Before: Committee on Foreign Relations, United States Senate

November 8, 2005-- Norka Ruiz Bravo, Ph.D., Deputy Director for Extramural Research, Office of Extramural Research, NIH/DHHS
Subject: The Small Business Innovation Research Program � Opening Doors to New Technology
Before: The Subcommittee on Workforce, Empowerment, and Government Programs, Small Business Committee, United States House of Representatives

November 8, 2005-- Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services
Subject: The HHS Pandemic Influenza Plan
Before: The Committee on Energy and Commerce, United States House of Representatives

November 4, 2005-- Michael O. Leavitt, Secretary, Department of Health and Human Services
Subject: The HHS Pandemic Influenza Plan
Before: The Committee on Government Reform, United States House of Representatives

November 2, 2005-- Michael O. Leavitt, Secretary, Department of Health and Human Services
Subject: Pandemic Influenza
Before: U.S. House Committee on Appropriations, Subcommittee on Labor, Health and Human Services and Education

November 2, 2005-- Michael O. Leavitt, Secretary, Department of Health and Human Services
Subject: Pandemic Influenza
Before: U.S. Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education

November 1, 2005-- Randall W. Lutter, Ph.D., Acting Associate Commissioner for Policy and Planning, FDA
Subject: Counterfeit Drugs Within The United States
Before: Subcommittee on Criminal Justice, Drug Policy, and Human Resources, Committee on Government Reform, House of Representatives

October 20, 2005-- Stephenie Colston, Senior Advisor to the Administrator, SAMHSA, DHHS
Subject: Comprehensively Combating Methamphetamines: Impacts on Health and the Environment
Before: The Subcommittee on Health and the Subcommittee on the Environment and Hazardous Materials, Committee on Energy and Commerce

September 29, 2005-- Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare and Medicaid Servcies, Department of Health and Human Services
Subject: Value-Based Purchasing for Physicians under Medicare
Before: House Ways and Means Subcommittee on Health

September 29, 2005-- Henry Falk, M.D., M.P.H., Director, Coordinating Center for Environmental Health, and Injury Prevention, Agency for Toxic Substances, and Disease Registry, Centers for Disease Control and Prevention, CDC/DHHS
Subject: ATSDR�s Emergency Response Activities and Hurricane Katrina Efforts
Before: The House Energy and Commerce Subcommittee on Environment and Hazardous Materials, United States House of Representatives

September 29, 2005-- Rachel E. Behrman, M.D., M.P.H., Deputy Director, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, DHHS
Subject: The Impact of Direct-To-Consumer Drug Advertising on Seniors' Health and Health Care Costs
Before: Special Committee on Aging, United States Senate

September 27, 2005-- Josephine Robinson, Director, Office of Community Services, Administration for Children and Families, Department of Health and Human Services
Subject: Low Income Home Energy Assistance Program (LIHEAP)
Before: Subcommittee on Federal Financial Management, Government Information and International Security, Committee on Homeland Security and Governmental Affairs, United States Senate

September 22, 2005-- Leslie Norwalk, Deputy Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Cost and Medicare Part D
Before: Senate Subcommittee on Federal Financial Management, Government Information and International Security of the Committee on Homeland Security and Government Affairs

September 13, 2005-- Robert J. Meyer, M.D., Director, Office of Drug Evaluation II, Center for Drug Evaluation and Research, FDA, HHS
Subject: FDA's Role in Preventing Prescription Drug Abuse
Before: Subcommittee on Regulatory Affairs, Committee on Government Reform, U.S. House of Representatives

September 7, 2005-- Richard Pazdur, M.D., Director, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, U. S. Department of Health and Human Services
Subject: Women and Cancer � Where Are We in Prevention, Early Detection and Treatment of Gynecologic Cancers?
Before: The Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, United States House of Representatives

September 7, 2005-- Edward L. Trimble, M.D., M.P.H., Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, DHHS
Subject: National Cancer Institute Research and Education Efforts on Gynecological Cancers
Before: The Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, United States House of Representatives

September 7, 2005-- Ed Thompson, M.D., M.P.H., Chief of Public Health Practice, Centers for Disease Control and Prevention, HHS
Subject: Centers for Disease Control and Prevention Public Health Work Relating to Gynecological Cancers
Before: The Subcommittee on Criminal Justice, Drug Policy, and Human, Resources, Committee on Government Reform, United States House of Representatives

July 28, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, DHHS
Subject: Implementing a National Biodefense Strategy
Before: The Committee on Homeland Security, Subcommittee on Prevention of Nuclear and Biological Attack, United States House of Representatives

July 28, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institute of Health, HHS
Subject: The NIH Biomedical Research Response to the Threat of Bioterrorism
Before: The Committee on Homeland Security, Subcommittee on the Prevention of Nuclear and Biological Attack, United States House of Representatives

July 21, 2005-- Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare & Medicaid Services (CMS)
Subject: Value-Based Purchasing for Physicians Under Medicare
Before: House Ways and Means Subcommittee on Health

July 20, 2005-- Robert E. Brackett, Ph.D., Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration
Subject: Food Counterterrorism Activities
Before: Committee on Agriculture, Nutrition, and Forestry, United States Senate

July 20, 2005-- James Scanlon, Acting Deputy, Assistant Secretary for Science and Data Policy, DHHS
Subject: Information Quality Act (IQA)
Before: The U.S. House of Representatives Government Reform Committee, Subcommittee on Regulatory Affairs

July 20, 2005-- Michael O. Leavitt, Secretary, Department of Health and Human Services
Subject: Health Information Technology (IT)
Before: The Committee on the Budget, United States Senate

July 19, 2005-- Kiyohiko Mabuchi, M.D., Dr. P.H., Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: NCI's Development of Baseline Cancer and Radiation - Related Illness Rates Relating to Nuclear Weapons Testing in the Marshall Islands
Before: Committee on Energy and Natural Resource, United States Senate

July 19, 2005-- Elias A. Zerhouni, M.D., Director, National Institutes of Health, U.S. Department of Health and Human Services
Subject: The Search for a Better Way: Reauthorization of The National Institutes of Health
Before: Committee on Energy and Commerce, United States House of Representatives

July 14, 2005-- Witness: Dr. Charles W. Grim, Director, Indian Health Service, Department of Health and Human Services
Subject: S.1057 - Indian Health Care Improvement Act Amendments of 2005
Before: Committee on Indian Affairs, Health, Education, Labor and Pensions Committee, United States Senate

July 14, 2005-- Witness: Stewart Simonson, Assistant Secretary, Office of Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: The Role of HHS in the Development and Acquisition of Medical Countermeasures Under Project BioShield
Before: The Committee on Government Reform, United States House of Representatives

July 14, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, HHS
Subject: NIH Implementation of Project BioShield in the Research and Development of Defense Countermeasures
Before: The Committee on Government Reform, United States House of Representatives

July 14, 2005-- Wade F. Horn, Ph.d., Assistant Secretary for Children and Families, HHS
Subject: Employment Levels of Temporary Assistance for Needy Families (TANF) Families
Before: The Human Resources Subcommittee, Ways and Means Committee, U.S. House of Representatives

July 12, 2005-- Dr. Michael O�Grady, Assistant Secretary for Planning and Evaluation, Department of Health and Human Services
Subject: Examine Youth Development Program Coordination
Before: House Committee on Education and the Workforce, Subcommittee on Select Education, U.S. House of Representatives

July 12, 2005-- James F. Battey, M.D., Ph.D., Director, National Institute on Deafness and Other Communication, Disorders, and Chair, NIH Stem Cell Task Force, HHS
Subject: Alternative Methods of Obtaining Embryonic Stem Cells
Before: The Subcommittee On Labor, Health and Human Services, Education, and Related Agencies, Committee on Appropriations, United States Senate

July 12, 2005-- Tim Hill, Director, Office of Financial Management, Centers for Medicare & Medicaid Services, HHS
Subject: Medicare and Medicaid Improper Payments
Before: The Senate Homeland Security and Governmental Affairs Subcommittee on Federal Financial Management, Government Information and International Security

July 12, 2005-- Stewart Simonson, Assistant Secretary, Office of Public Health Emergency Preparedness, HHS
Subject: The Role of HHS in the Procurement of Security Countermeasures under Project BioShield: Linking Threats to Acquisition Programs
Before: The Committee on Homeland Security, Subcommittee on Emergency Preparedness, Science, and Technology, U.S. House of Representatives

June 30, 2005-- James W. LeDuc, Ph.D., Director, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, HHS
Subject: The Next Flu Pandemic: Evaluating U.S. Preparedness
Before: The Committee on Government Reform, United States House of Representatives

June 30, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institute of Health, HHS
Subject: The Role of NIH Biomedical Research in Pandemic Influenza Preparedness
Before: The Committee on Government Reform, United States House of Representatives

June 30, 2005-- Bruce G. Gellin, M.D., Director, National Vaccine Program Office, Office of Public Health and Science, Office of the Assistant Secretary for Health, HHS
Subject: Pandemic Influenza Preparedness
Before: The Committee on Government Reform, United States House of Representatives

June 30, 2005-- David J. Brailer, MD, Ph.d, National Coordinator for Health Information Technology, HHS
Subject: Activities of the Office of the National Coordinator for Health Information Technology
Before: The Committee on Commerce, Science, and Transportation Subcommittee on Technology, Innovation, and Competitiveness, US Senate

June 30, 2005-- Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality, HHS
Subject: Health Information Technology Activities at the Agency for Healthcare Research and Quality
Before: The Committee on Commerce, Science, and Transportation Subcommittee Technology Innovation, and Competitiveness, US Senate

June 28, 2005-- Dennis G. Smith, Director, Center for Medicaid and State Operations in the Centers for Medicare & Medicaid Services
Subject: Medicaid Oversight
Before: The Senate Finance Committee

June 23, 2005-- Anthony S. Fauci, M.D., Director, National Institute of ALlergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: The Role of NIH Biomedical Research in the Development of an HIV Vaccine
Before: The Committee on Foreign Relations, United States Senate

June 23, 2005-- Deborah Parham Hopson, Ph.D., Assoicate Administrator HIV/AID Bureau Health Resources and Services Administration
Subject: Domestic HIV/AIDS Care Programs
Before: Committee on Homeland Security and Governmental Affairs, Subcommittee on Federal Financial Management, Government Information, and International Security

June 23, 2005-- Roberts S. Janssen, MD, Director, Divisions of HIV/AIDS Prevention National Cancer for HIV, STD, and TB Prevention Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention, HHS
Subject: Domestic HIV/AIDS Surveillance: Current Trends and Status of HIV Reporting
Before: Senate Homeland Security and Governmental Affairs Subcommittee on Federal Financial Management, Government Information, and International Security

June 23, 2005-- Wade F. Horn, Ph.D., Assistant Secretary for Children and Families, HHS
Subject: Reauthorization of the Torture Victims Relief Act of 1988
Before: Committee on International Relations, Subcommittee on Africa, Global Human Rights, and International Operations, U.S. House of Representatives

June 21, 2005-- Allen M. Spiegel, M.D., Director, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Recent Devlopments in Research on Type 1 Diabetes
Before: The Committee on Homeland Security and Government Affairs

June 16, 2005-- Herb Kuhn, Director, Center for Medicare Management, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services
Subject: Standardized Payment and Patient Assessments in Post-Acute Care
Before: Subcommittee on Health of the House Committee on Ways and Means

June 15, 2005-- Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Steriod Use Among Females: Results of the Youth Risk Behavioral Surveillance System (YRBSS)
Before: Committee on Government Reform, U.S. House of Representatives

June 15, 2005-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Office of Public Health and Science, U.S. Department of Health and Human Service
Subject: Suicide Prevention Among Native American Youth
Before: The Indian Affairs Committee, United States Senate

June 14, 2005-- Robert E. Brackett, Ph.D., Director, Center for Food Safety and Applied Nutrition, Food and Drug Administration, U.S. Department of Health and Human Services
Subject: Biotech Foods
Before: The Committee on Agriculture, Nutrition, and Forestry, U.S. Senate

June 14, 2005-- Stewart Simonson, Assistant Secretary, Office of Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: The Role of HHS in the Development and Acquisition of Medical Countermeasures for Chemical, Biological, Radiological and Nuclear (CBRN) Threats
Before: The Committee on Government Reform, Subcommittee on National Security, Emerging Threats, and International Relations, U.S. House of Representatives

June 14, 2005-- Roberto Hugh Potter, Ph.D., Office of Health Disparities, Corrections and Substance Abuse Activities, National Center for HIV, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Disease Transmission and Injury in Prisoner Rape Events: Concerns for Corrections and the Community
Before: The National Prison Rape Elimination Commission

June 9, 2005-- Wade F. Horn, PH.D., Assistant Secretary for Children and Families, HHS
Subject: Current State of Child Welfare Financing and the Need for Reform
Before: The Committee on Ways and Means, Subcommittee on Human Resources, U.S. House of Representatives

June 9, 2005-- Carolyn M. Clancy, M.D., Director, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
Subject: Patient Safety Activities at the Department of Health andHuman Services
Before: Committee on Energy and Commerce, Subcommittee on Health

June 9, 2005-- William F. Raub, Ph.D., Deputy Assistant Secretary, Office of Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: BioShield: HHS Biodefense Preparedness Efforts
Before: Committee on Health, Education, Labor and Pensions, Subcommittee on Bioterrorism and Public Health Preparedness

June 7, 2005-- Susan Orr, Ph.D, Associate Commissioner of the Children's Bureau, Administration for Children and Families, HHS
Subject: Domestic Human Trafficking
Before: The Commission on Security and Cooperation in Europe (The Helsinki Commission), US Congress

May 26, 2005-- Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare and Medicaid Services, Department of Health and Human Services
Subject: Tax Examption for Hospitals and Federal Payment for Uncompensated Cares
Before: Committee on Ways and Means

May 26, 2005-- Bruce G. Gellin, M.D., M.P.H., Director, National Vaccine Program Office, Office of Public Health and Science, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services
Subject: Pandemic Influenza Preparedness
Before: Committee on Energy and Commerce, Subcommittee on Health, United States House of Representatives

May 26, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Pandemic Planning and Preparedness
Before: Committee on Energy and Commerce, Subcommittee on Health, United States of Representatives

May 26, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, Natoinal Institutes of Health, U.S. Department of Health and Human Services
Subject: The Role of NIH Biomedical Research in Pandemic Influenza Preparedness
Before: The Committee on Energy and Commerce, Subcommittee on Health, United States House of Representatives

May 25, 2005-- Dennis Smith, Director, Center for Medicaid and State Operations, Centers for Medicare and Medicaid Services
Subject: Community Health Centers
Before: The House Energy and Commerce Subcommittee on Oversight and Investigations

May 25, 2005-- Elizabeth M. Duke, Ph.D, Administrator, Health and Resources and Services Administratin, HHS
Subject: "A Review of Community Health Centers: Issues and Opportunities"
Before: The Subcommittee on Onversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives

May 18, 2005-- Carolyn M. Clancy, M.D., Director, Agency for Healthcare Research, Department of Health and Human Services
Subject: Telemedicine Activities at the Department of Health and Human Services
Before: The Subcommittee on Health Committee on Veterans Affairs, United States House of Representatives

May 18, 2005-- Donald Young, M.D., Principal Deputy Assistant Secretary for Planning and Evaluation, Department of Health and Human Services
Subject: Protections of Children Enrolled in Clinical Trials
Before: The Subcommittee on Human Resources Committee on Ways and Means, United States House of Representatives

May 17, 2005-- Robert L. Stephenson, M.P.H., Director, Division of Workplace Programs, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Subject: Products Used to Thwart Detection in Drug Testing Programs
Before: Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, U.S. House of Repesentatives

May 17, 2005-- Josefina Cabonell, Assistant Secretary for Aging, HHS
Subject: Reauthorization of the Older Americans Act
Before: The Subcommittee on Retirement Security and Aging Committee on Health, Education, Labor and Pensions, US Senate

May 17, 2005-- Robert E. Brackett, Ph.D., Director, Center for Food Safety and Applied Nutruition, Food and Drug Administration, Department of Health and Human Services
Subject: "Question: What is More Scrambled Than an Egg? Answer: THe Federal Food Inspection System."
Before: Committee on Government Reform, Subcommittee on the Federal Workforce and Agency Organization, U.S. House of Representatives

May 12, 2005-- Robert S. Janssen, M.D., Director, Division of HIV/AIDS, Prevention, National Center for Infectious Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: HIV/AIDS in Persons 50 Years of Age and Older
Before: The Special Committee on Aging, United States Senate

May 12, 2005-- Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare and Medicaid Services, Dept. of Health and Human Services
Subject: Specialty Hospitals: Assessing Their Role in the Delivery of Quality Health Care
Before: The House Committee on Energy and Commerce

May 11, 2005-- John Wheeler, Ph.D., D.A.B.T., Environmental Health Scientist, Senior Toxicoligist, Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services
Subject: ATSDR's Asbestos-Related Work in El Dorado Hills, California
Before: Joint Informational Hearing of the Health Committee and Environmental Quality Committee, California State Senate

May 11, 2005-- Andrew C. von Eschenbach, M.D., Director, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Activities at the National Cancer Institute Concerning Gynecological Cancers
Before: The Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

May 11, 2005-- Story C. Landis, Ph.D., Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, U.S. Department and Human Services
Subject: Current Research on Amyotrophic Lateral Sclerosis
Before: The Subcommittee on Labor, Health and Human Services Education and Related Agencies Committee on Appropriations, United States Senate

May 11, 2005-- LT Michelle Colledge, Environmental Health Scientist Division of Regional Operations, Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services
Subject: ATSDR's Public Health Activities in Warreb Township, Ohio
Before: The Economic Decelopment and Environment Committee, Ohio State Senate

May 5, 2005-- Steven Galson, M.D., M.P.H., Acting Director, Center for Drug Evaluation and Research
Subject: Drug Safety
Before: Committee on Government Reform, U.S. House of Representatives

May 4, 2005-- Jesse L. Goodman, M.D., M.P.H., Director, Center for Biologics, Evaluation and Research, Food and Drug Administration , U.S. Department of Health and Human Services
Subject: Influenza Vaccine: The State of Readiness for the 2005-2006 Flu Season
Before: The Committee on Energy and Commerce, United States House of Representatives

May 4, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: US Influenza Vaccine Supply and Preparations for the Upcoming Influenza Season
Before: The Subcommittee on Oversight and Investigations Committee on Energy and Commerce, United States House of Representatives

May 4, 2005-- Bruce G. Gellin, M.D., M.P.H., Director, National Vaccine Program Office, Office of the Assistant Secretary of Health, U.S. Department of Health and Human Services
Subject: Annual Influenza and Pandemic Influenza Preparedness
Before: The Subcommittee on Oversight and Investigations Committee on Energy and Commerce, United States House of Representatives

May 2, 2005-- Charles W. Grim, D.D.S., M.H.S.A., Director, Indian Health Service, U.S. Department of Health and Human Services
Subject: Teen Suicide Among American Indian YouthUnited States Senate
Before: Committee on Indian Affairs, United States Senate

May 2, 2005-- Ulonda Shamwell, M.S.W., Director, Division of Policy Coordination, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Subject: SAMHSA's Efforts to Provide Mental Health and Substance Abuse Services to American Indians and Alaska Natives
Before: Committee on Indian Affairs, United States Senate

April 28, 2005-- Stewart Simonson, J.D., Assistant Secretary, Office of Public Health Emergency Preparedness, U.S. Department of Health and Human Services
Subject: BioShield: HHS Biodefense Preparedness Efforts
Before: Committee on Appropriations, Subcommittee on Homeland Security, United States Senate

April 28, 2005-- Mark B. McClellan, MD, Ph.D, Administrator, Centers for Medicaid and Medicare Services, Department of Health and Human Services
Subject: Malpractice Liability Reform
Before: Joint Economic Committee

April 27, 2005-- Mark B. McClellan, MD, Ph.D, Administrator, Centers for Medicaid and Medicare Services, Department of Health and Human Services
Subject: Long-Term Care and Medicaid: Better Quality and Sustainability By Giving More Control to People with a Disability
Before: Subcommittee on Health, House Committee on Energy and Commerece

April 26, 2005-- Charles Curie, M.A. A.C.S.W., Administrator, Substance Abuse and Mental Health Service Administration, U.S. Department of Health and Human Services
Subject: Substance Abuse Prevention Programs of the Substance Abuse and Mental Health Services Administration
Before: Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, United States House of Representatives

April 21, 2005-- Nora D. Volkow, M.D., Director, National Insitute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Methamphetamine Abuse
Before: The Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Committee on Appropriations, United States Senate

April 21, 2005-- Charles Curie, M.A., A.C.S.W., Administrator, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Subject: Prevention and Treatment of Methamphetamine Abuse
Before: Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Committee on Appropriations, United States Senate

April 20, 2005-- Wade F. Horn, Ph.D., Assistant Secretary for Children and Families, U.S. Department of Health and Human Services
Subject: The Head Start and Child Care Programs
Before: The Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Education and Early Childhood Development

April 13, 2005-- Charles W. Grim, D.D.S., M.H.S.A., Director, Indian Health Service, Department of Health and Human Services
Subject: The Status of Indian Health
Before: The Committee on Indian Affairs, United States Senate

April 13, 2005-- A. Kathryn Power, M.Ed., Director, Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Subject: SAMHSA's Efforts to Provide Mental Health and Substance Abuse Services to American Indians and Alaska Natives
Before: The Committee on Indian Affairs, United States Senate

April 12, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Influenza Preparedness
Before: The Subcommittee on Labor/HHS/Education and Related Agencies, Appropriations Subcommittee, United States House of Representatives

April 12, 2005-- Anthony S. Fauci, M.D., Director, National Institute of ALlergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services
Subject: The Role of NIH Biomedical Research in Pandemic Influenza Preparedness
Before: The House Committee on Appropriations, Subcommittee on Labor, HHS, and Education, United States House of Representatives

April 12, 2005-- Bruce Gellin, Director, National Vaccine Program, U.S. Department of Health and Human Services
Subject: Influenza Preparedness
Before: The Subcommittee on Labor/HHS/Education and Related Agencies Appropriations, United States House of Representatives

April 6, 2005-- Anne Schuchat, M.D., Acting Director, National Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: CDC Efforts to Prevent Pandemics by Air Travel
Before: Committee on Transportation and Infrastructure, Subcommittee on Aviation, United States House of Representatives

April 5, 2005-- Wade F. Horn, PH.D, Assistant Secretary for Children and Families, HHS
Subject: Head Start: Comprehensive Approach to Identifying and Addressing Risks Could Help Prevent Grantee Financial Management Weaknessess
Before: The Committee on Health, Education, Labor and Pensions, U.S. Senate

April 5, 2005-- Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare & Medicaid Services, Department of Health and Human Services
Subject: Monitoring CMS' Vital Signs: Implementation of the Medicare Prescription Drug Benefit
Before: Subcommittee on Oversight of Government Management, the Federal Workforce, and the District of Columbia, Committee on Homeland Security and Government Affairs, U.S. Senate

April 5, 2005-- Tanja Popovic, M.D., Ph.D., Acting Associate Director for Science, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Assessing Anthrax Detection Methods
Before: The Committee on Government Reform, Subcommittee on National Security, Emerging Threats, and International Relations, United States House of Representatives

March 17, 2005-- Nora D. Volkow, M.D., Director, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Subject: Consequences of the Abuse of Anabolic Steroids
Before: Committee on Government Reform, United States House of Representatives

March 17, 2005-- Elias A. Zerhouni, M.D., Director, National Institutes of Health, Department of Health and Human Services
Subject: Setting the Path for Reauthorization: Improving Portfolio Management at NIH
Before: Committee on Energy and Commerce, Subcommittee on Health, United States House of Representatives

March 16, 2005-- George A. Mensah, M.D., Acting Director, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: Colorectal Cancer Screening
Before: The Cancer Coalition, United States Senate

March 15, 2005-- Herb Kuhn, Director, Center for Medicare Management, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services
Subject: Pay for Performance Initiatives
Before: Subcommittee on Health of the Committee on Ways and Means

March 15, 2005-- Wade F. Horn, Ph.D. Assistant Secretary, Administration for Children and Families
Subject: Welfare Reform Reauthorization
Before: Subcommittee on 21st Century Competitiveness, House Committee on Education and the Workforce

March 9, 2005-- Allen Dearry, Ph.D. Associate Director for Research Coordination, Planning and Translation, National Institute of Environmental Health Sciences National Institutes of Health U.S. Department of Health and Human Services
Subject: The Implementation of Geoss: A Review of the All-Hazards Warnings Sytem and its Benefits to Public Health, Energy and the Environment
Before: The Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, United States House of Representatives

March 8, 2005-- Thomas A. Gustafson, Ph.D., Deputy Director, Center for Medicare and Medicaid Services Department of Health and Human Services
Subject: Physician-Owned Speciality Hospitals
Before: Senate Committee on Finance

March 3, 2005-- Janet Woodcock, M.D., Acting Deputy Commissioner for Operations, U.S. Food and Drug Administration, Department of Health and Human Services
Subject: Drug Safety and the Drug Approval Process
Before: The Committee on Health, Education, Labor and Pensions, United States Senate

March 3, 2005-- Michael O. Leavitt, Secretary, Department of Health and Human Services
Subject: President's FY 2006 Budget for The Department of Health and Human Services
Before: U.S. House of Representatives, Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

March 3, 2005-- Mark McClellan, MD, Ph.D., Administrator, Centers for Medicare & Medicaid Services
Subject: The Transition of Full-Benefit Dual Eligible Beneficiaries to the Medicare Prescription Drug Benefit
Before: Senate Special Committee on Aging

March 2, 2005-- Michael J. O'Grady, PH.D, Assistant Secretary for Planning and Evaluation, HHS
Subject: Presidents Proposal for Making Health Care More Affordable
Before: The Committee on Small Business, U.S. House of Representatives

March 1, 2005-- Sandra L. Kweder, M.D., Deputy Director, Office of New Drugs, U.S. Food and Drug Administration, Department of Health and Human Services
Subject: Drug Saftey and the Drug Approval Process
Before: The Committee on Health, Education, Labor and Pensions, United States Senate

February 17, 2005-- The Honorable Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services
Subject: FY 2006 Budget
Before: The Committee on Ways and Means, United States House of Representatives

February 17, 2005-- The Honorable Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services
Subject: FY06 Budget for the Department of Health and Human Services
Before: The Committee On Energy and Commerce, United States House of Representatives

February 16, 2005-- Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Department of Health and Human Services
Subject: Report of the HHS Task Force on Drug Importation
Before: Committee on Health, Eductaion, Labor, and Pensions, United States Senate

February 16, 2005-- Charles W. Grim, D.D.S., M.H.S.A., Assistant Surgeon General, Director, Indian Health Service
Subject: The President's FY 2006 Budget Request
Before: Committee on Indian Affairs, United States Senate

February 16, 2005-- The Honorable Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services
Subject: Budget Hearing FY06
Before: The Committee on Finance, United States Senate

February 10, 2005-- Julie L. Gerberding, M.D., M.P.H., Director, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services
Subject: US Influenza Supply and Preparations for the Future
Before: The Committee on Government Reform, United States House of Representatives

February 10, 2005-- Jesse L. Goodman, M.D., M.P.H., Director, Center for Biologics, Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services
Subject: Influenza Vaccine: Current Status, Lessons Learned and Preparing for the Future
Before: The Committee on Government Reform, United States House of Representatives

February 10, 2005-- Wade F. Horn, Ph.D., Assistant Secretary, Administration for Children and Families
Subject: Welfare Reform Reauthorization Proposals
Before: The Subcommittee on Human Resources, House Ways and Means Committee

February 8, 2005-- Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services
Subject: The NIH Biodefense Research Program
Before: The Subcommittee on Bioterrorism and Public Health Preparedness, Committee on Health, Education, Labor and Pensions, United States Senate

January 26, 2005-- Richard H. Carmona, M.D., M.P.P.H., F.A.C.S., Surgeon General, U.S. Public Health Service, Department of Health and Human Services
Subject: Report of the HHS Task Force on Drug Importation
Before: The Special Committee on Aging, United States Senate

Last Revised: March 12, 2007

Other HHS Sites of Interest